CASTRATION-RESISTANT PROSTATIC CANCER
Clinical trials for CASTRATION-RESISTANT PROSTATIC CANCER explained in plain language.
Never miss a new study
Get alerted when new CASTRATION-RESISTANT PROSTATIC CANCER trials appear
Sign up with your email to follow new studies for CASTRATION-RESISTANT PROSTATIC CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heartburn drug may boost chemo against tough prostate cancer
Disease control Recruiting nowThis study tests whether adding omeprazole (a common heartburn drug) to chemotherapy (cabazitaxel or docetaxel) can help control advanced prostate cancer that has stopped responding to standard treatments. About 50 men with castration-resistant prostate cancer that progressed aft…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 16, 2026 22:29 UTC
-
New hope for hard-to-treat prostate cancer: experimental drug combo enters human trials
Disease control Recruiting nowThis study tests a new drug called ifinatamab deruxtecan, given alone or with other treatments, in people whose prostate cancer has spread and stopped responding to hormone therapy. The goal is to find safe doses and see if the drug can shrink tumors or lower PSA levels. About 36…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE1, PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
New hope for tough prostate cancer? early trial launches
Disease control Recruiting nowThis early-phase study tests a new drug called JANX007 in men with advanced prostate cancer that has stopped responding to standard treatments. The main goals are to check the drug's safety and find the right dose. About 272 men will take part in this first human study.
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: Janux Therapeutics • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
New drug MGC026 enters human testing for advanced cancers
Disease control Recruiting nowThis study is testing an experimental drug called MGC026 in about 250 adults with advanced solid tumors that have not responded to other treatments. The main goals are to check the drug's safety and find the right dose. Participants receive the drug by IV and are closely monitore…
Matched conditions: CASTRATION-RESISTANT PROSTATIC CANCER
Phase: PHASE1 • Sponsor: MacroGenics • Aim: Disease control
Last updated May 11, 2026 20:50 UTC